2020
DOI: 10.1007/s11920-020-01182-z
|View full text |Cite
|
Sign up to set email alerts
|

Screening for Mental Health and Substance Use Disorders in Obstetric Settings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 133 publications
0
14
0
Order By: Relevance
“…Eighty-nine percent of clinicians in our study reported consistently screening for depression. These screening rates are at the higher end of the estimated national average of 50 À 98% [24,25]. It is known that self-reported and actual screening rates are not always concordant, but this rate is still markedly higher than the percentage of clinicians who report treating depression regularly, illuminating the gap in care.…”
Section: Discussionmentioning
confidence: 99%
“…Eighty-nine percent of clinicians in our study reported consistently screening for depression. These screening rates are at the higher end of the estimated national average of 50 À 98% [24,25]. It is known that self-reported and actual screening rates are not always concordant, but this rate is still markedly higher than the percentage of clinicians who report treating depression regularly, illuminating the gap in care.…”
Section: Discussionmentioning
confidence: 99%
“…Suicide and drug overdose combine to constitute the leading cause of maternal mortality during pregnancy and the postnatal period ( 4 , 5 ), with PMADs, PSUDs and IPV increasing this risk. Additionally, each of these disorders contribute to significant maternal and child morbidity ( 6 , 7 ). Despite strong recommendations from virtually all professional societies to implement effective screening and referral processes, the uptake of these recommendations has been limited and many screening and referral practices are largely ineffective.…”
Section: Discussionmentioning
confidence: 99%
“…Perinatal Mood and Anxiety Disorders (PMADs), Perinatal Substance Use Disorders (PSUDs) and Intimate Partner Violence (IPV) are common during pregnancy and the postpartum year ( 1 , 2 , 3 ), and have been strongly associated with significant morbidity and mortality for both women and their children ( 4 , 5 ). Multiple professional organizations have endorsed screening for PMADs, PSUDs and IPV during pregnancy and the postpartum period using standardized, validated screening tools, followed by assessment and referral to treatment ( 6 ). For those screening positive for substance use, a brief intervention using in‐person motivational interviewing to support behavioral change and referral to treatment (e.g., Screening, Brief Intervention and Referral to Treatment [SBIRT]) is recommended ( 7 , 8 ).…”
mentioning
confidence: 99%
“…Mood and anxiety disorders affect pregnant people and their families at increased rates throughout the perinatal period. Perinatal depression affects between 11-15% of obstetric populations [1][2][3][4]. According to a 2013 study by Wisner et al, individuals experienced onset of depressive episodes at the highest rate during postpartum (40.1%), pregnancy (33.4%), and before pregnancy (26.5%) [5].…”
Section: Introductionmentioning
confidence: 99%
“…Further, 19.3% of individuals across the peripartum period experience suicidal ideations [5], and suicidality in pregnancy and postpartum is on the rise in the US [6]. Of those who screen positive for unipolar depression, approximately 20% of individuals meet criteria for bipolar depression [1]. Anxiety affects up to 20% of individuals during pregnancy, and as many as 50% of individuals immediately postpartum [7].…”
Section: Introductionmentioning
confidence: 99%